Clinical Trial Update: Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 trial evaluating atezolizumab plus bevacizumab, with or without external beam radiotherapy, for hepatocellular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Asan Medical Center | Conditions: Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 2 | Status: RECRUITING